Unraveling the Regulatory Impact of LncRNA HNF1AOS1 on Hepatic Homeostasis in Mice

Abstract: Long noncoding RNAs (lncRNAs) play significant roles in tissue development and disease progression and have emerged as crucial regulators of gene expression. The hepatocyte nuclear factor alpha antisense RNA 1 (HNF1A-AS1) lncRNA is a particularly intriguing regulatory molecule in liver biology that is involved in the regulation of cytochrome P450 enzymes via epigenetic mechanisms. Despite the growing recognition of lncRNAs in liver disease, the comprehensive role of HNF1A-AS1 in liver function remains unclear. This study aimed to investigate the roles of the mouse homolog of the human HNF1A-AS1 lncRNA HNF1A opposite strand 1 (HNF1AOS1) in liver function, gene expression, and cellular pro-cesses using a mouse model to identify potential therapeutic targets for liver disor-ders. Knockdown of HNF1AOS1 was performed in in vitro mouse liver cell line using siRNA and in vivo livers of AAV-shRNA complexes. Changes in the global expression landscapes of mRNA and proteins were revealed using RNA-seq and proteomics, respectively. Changes in the selected genes were further validated by real-time quantitative polymerase chain reaction (RT-qPCR). Phenotypic changes were assessed by histological and absorbance-based assays.  After the knockdown of HNF1AOS1, RNA-seq and proteomics analysis revealed differential gene expression of mRNAs and proteins involved in the processes of molecular transport, liver regeneration, and immune signaling pathways. Downregulation of ABCA1 and SREBF1 in-dicates its role in cholesterol transport and fatty acid and triglyceride synthesis. Additionally, significant reductions in hepatic triglyceride levels were observed in the HNF1AOS1-knockdown group, underscoring its impact on lipid regulation. Notably, the knockdown of HNF1AOS1 also led to an almost complete depletion of CYP7A1, the rate-limiting enzyme in bile acid synthesis, highlighting its role in cholesterol homeostasis and hepatotoxicity. Histological assessments confirmed these molecular findings, with increased hepatic inflammation, hepatocyte swelling, and disrupted liver architecture observed in the HNF1AOS1-knockdown mice. This study illustrated that HNF1AOS1 is a critical regulator of liver health, influencing both lipid metabolism and immune pathways. It maintains hepatic lipid homeostasis, modulates lipid-induced inflammatory responses, and contributes to viral immunity, indirectly affecting glucose and lipid metabolic balance.